Drug intelligence / Profile preview

levofloxacin + azithromycin

Development stage
Unknown
Lead developer
Daiichi Sankyo
Modality
Small Molecules
Administration
Oral
01

Overview

Levofloxacin + azithromycin is a fixed-dose combination of two antibiotics used to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and cervicitis. Levofloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and repair in bacteria. Azithromycin is a macrolide antibiotic that binds to the 50S subunit of the bacterial ribosome, inhibiting protein synthesis by blocking the nascent peptide exit tunnel on 23S rRNA. The combination provides broad-spectrum coverage against both gram-positive and gram-negative bacteria as well as atypical pathogens. Clinical studies suggest this combination may be more effective than monotherapy in certain indications such as cervicitis[1][4][5][8].

Brand names
Levomac AZZithrox LXLevole ZQulef ZXUVAzilin LLoxof AZAzibact LAtm LX
Other names
azithromycin + levofloxacin
02

Targets

Bacterial 50S ribosomal subunitDNA gyraseTopo IV (Bacterial Topoisomerase IV)

Beyond the preview

Go deeper on levofloxacin + azithromycin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on levofloxacin + azithromycin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call